Pharmaceuticals
This New ETF Is Totally a Wild
AdvisorShares Psychedelics ETF, which is adding Mindset Pharma and lists Cybin as a top holding, looks like a good trip.
Amarin Charts Are Charting a Course Toward Improvement
However, traders will need to show a lot of patience if they buy shares of the biopharmaceutical company.
Why Biopharmaceutical Dynavax Technologies Could Soar in 2022
Here's how traders can play the stock.
3 Big Pharma Buys for Dividend Investors
In a market with elevated valuations and low yields, we see pharmaceutical stocks as a respite from both.
Figuring Out How to Play the S&P 500 Pullback and Johnson & Johnson
It's time to turn to the chart to determine whether the pullback is an opportunity to buy or if it is something more.
Biohaven Pharmaceutical Is Charging Higher
Here's where it might be headed.
Vertex Pharmaceuticals Is in a Long-Term Decline
But the worst appears to be behind them.
A Day Never to Forget, Red-Hot Debt Market, Moderna Marches On, Biden Thumbs Up
Plus, Zscaler largely delivers for its owners with its latest results.
Moderna Poised to Get a Boost
The charts and indicators tell us the correction is over.
3 High-Yield Dividend Stocks With an International Flavor
BP, Novartis and British American Tobacco offer healthy payouts that look secure for years to come.